• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 69-83 of 113 results

2007 Exhibit: Intl Pub No WO 2010135703A2 by Ahmad et al

Document PGR2023-00043, No. 2007 Exhibit - Intl Pub No WO 2010135703A2 by Ahmad et al (P.T.A.B. Nov. 30, 2023)

cite Cite Document

2002 Exhibit: Elkins et al, Characterization of the isomeric configuration

Document PGR2023-00043, No. 2002 Exhibit - Elkins et al, Characterization of the isomeric configuration (P.T.A.B. Nov. 30, 2023)

cite Cite Document

2019 Exhibit: Susan M Krumplitsch Declaration in Support of Motion for Pro Hac Vic...

Document PGR2023-00043, No. 2019 Exhibit - Susan M Krumplitsch Declaration in Support of Motion for Pro Hac Vice (P.T.A.B. Nov. 30, 2023)

cite Cite Document

2006 Exhibit: Excerpt of ’151 Patent File History FOA and NOA “’985 File History 3”

Document PGR2023-00043, No. 2006 Exhibit - Excerpt of ’151 Patent File History FOA and NOA “’985 File History 3” (P.T.A.B. Nov. 30, 2023)

cite Cite Document

2016 Exhibit: Buchanan et al, “Solubilization and Dissolution of Tamoxifen Hydroxy...

Document PGR2023-00043, No. 2016 Exhibit - Buchanan et al, “Solubilization and Dissolution of Tamoxifen Hydroxybutenyl Cyclodextrin Complexes,” J Pharm Sciences, 95102246 2255 2006 “Buchanan” ...

cite Cite Document

2004 Exhibit: Excerpt of ’151 Patent File History IDS Filings, Receipts, List Conside...

Document PGR2023-00043, No. 2004 Exhibit - Excerpt of ’151 Patent File History IDS Filings, Receipts, List Considered (P.T.A.B. Nov. 30, 2023)

cite Cite Document

2012 Exhibit: International Counsel for Harmonisation of Technical Requirements fo...

Document PGR2023-00043, No. 2012 Exhibit - International Counsel for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (P.T.A.B. Nov. 30, 2023)

cite Cite Document

2011 Exhibit: Ali et al, “Endoxifen is a new potent inhibitor of PKC A potential therap...

Document PGR2023-00043, No. 2011 Exhibit - Ali et al, “Endoxifen is a new potent inhibitor of PKC A potential therapeutic agent (P.T.A.B. Nov. 30, 2023)

cite Cite Document

2014 Exhibit: Center for Drug Evaluation and Research, FDA Guidance Document,...

Document PGR2023-00043, No. 2014 Exhibit - Center for Drug Evaluation and Research, FDA Guidance Document, “Development of New Stereoisomeric Drugs,” (P.T.A.B. Nov. 30, 2023)

cite Cite Document

2018 Exhibit: Jacques et al, Enantiomers, Racemates, and Resolutions 1981 “Jacq...

Document PGR2023-00043, No. 2018 Exhibit - Jacques et al, Enantiomers, Racemates, and Resolutions 1981 “Jacques” (P.T.A.B. Nov. 30, 2023)

cite Cite Document

2005 Exhibit: Excerpt of ’151 Patent File History Liu “’985 File History 2”

Document PGR2023-00043, No. 2005 Exhibit - Excerpt of ’151 Patent File History Liu “’985 File History 2” (P.T.A.B. Nov. 30, 2023)

cite Cite Document

2009 Exhibit: Intl Pub No WO 2009120999A2 by Kushner et al

Document PGR2023-00043, No. 2009 Exhibit - Intl Pub No WO 2009120999A2 by Kushner et al (P.T.A.B. Nov. 30, 2023)

cite Cite Document

2015 Exhibit: Lv et al, “Synthesis of mixed E,Z , E , and Z norendoxifen with dual aro...

Document PGR2023-00043, No. 2015 Exhibit - Lv et al, “Synthesis of mixed E,Z , E , and Z norendoxifen with dual aromatase inhibitory and estrogen receptor modulatory activities,” (P.T.A.B. Nov. 30, 2023...

cite Cite Document

2017 Exhibit: Gupta et al, “Salts of Therapeutic Agents Chemical, Physicochemical...

Document PGR2023-00043, No. 2017 Exhibit - Gupta et al, “Salts of Therapeutic Agents Chemical, Physicochemical, and Biological Considerations,” Molecules, 231719 2018 “Gupta” (P.T.A.B. Nov. 30, 20...

cite Cite Document

2001 Exhibit: Expert Declaration of Stephen Graham Davies, D Phil “Davies Decl”

Document PGR2023-00043, No. 2001 Exhibit - Expert Declaration of Stephen Graham Davies, D Phil “Davies Decl” (P.T.A.B. Nov. 30, 2023)

cite Cite Document
<< 1 2 3 4 5 6 7 8 >>